Variant report
Variant | nsv982075 |
---|---|
Chromosome Location | chr8:5054171-5064511 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs114341427 | chr8:5058031-5058032 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs183355437 | chr8:5058039-5058040 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs548732658 | chr8:5058040-5058041 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs568223306 | chr8:5058043-5058044 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs35069610 | chr8:5058046-5058047 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs186531408 | chr8:5058053-5058054 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs10098798 | chr8:5058074-5058075 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs540161104 | chr8:5058077-5058078 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs558148921 | chr8:5058089-5058090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs556576561 | chr8:5058102-5058103 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs370010697 | chr8:5058104-5058105 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs577979175 | chr8:5058120-5058121 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs140073789 | chr8:5058125-5058126 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs573825075 | chr8:5058128-5058129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs557179400 | chr8:5058134-5058135 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs541116551 | chr8:5058137-5058138 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs538615885 | chr8:5058150-5058151 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs369248196 | chr8:5058156-5058157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs372528491 | chr8:5058169-5058170 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs10098917 | chr8:5058179-5058180 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs532767310 | chr8:5058182-5058183 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs546023677 | chr8:5058187-5058188 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs370730314 | chr8:5058200-5058201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs369042395 | chr8:5058211-5058212 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs10111706 | chr8:5058220-5058221 | Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
26 | rs191309805 | chr8:5058229-5058230 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs530791639 | chr8:5058248-5058249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs184554478 | chr8:5058257-5058258 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs567122572 | chr8:5058260-5058261 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs4641091 | chr8:5058271-5058272 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs74740182 | chr8:5058273-5058274 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs78424665 | chr8:5058275-5058276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs75369293 | chr8:5058287-5058288 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs144942285 | chr8:5058318-5058319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs34033408 | chr8:5058321-5058322 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs537695192 | chr8:5058335-5058336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs368288861 | chr8:5058337-5058338 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs145748170 | chr8:5058339-5058340 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs541153472 | chr8:5058357-5058358 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs552812830 | chr8:5058364-5058365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs577633188 | chr8:5058366-5058367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs189823670 | chr8:5058380-5058381 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs10102277 | chr8:5058392-5058393 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs530762381 | chr8:5058394-5058395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs76991036 | chr8:5058397-5058398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs138491044 | chr8:5058409-5058410 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs528249752 | chr8:5058411-5058412 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs546748473 | chr8:5058417-5058418 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs559609957 | chr8:5058433-5058434 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs533427133 | chr8:5058469-5058470 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Breast cancer | 21364760 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Type 2 diabetes | 21526130 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:5058000-5058400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
2 | chr8:5058000-5058600 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
3 | chr8:5058400-5062000 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
4 | chr8:5058600-5062200 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
5 | chr8:5062000-5066800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
6 | chr8:5062200-5062800 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
7 | chr8:5062800-5063200 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
8 | chr8:5063200-5064400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
9 | chr8:5063400-5065600 | Enhancers | Fetal Brain Female | brain |
10 | chr8:5063600-5065600 | Enhancers | Brain Germinal Matrix | brain |
11 | chr8:5063800-5065600 | Enhancers | Fetal Brain Male | brain |
12 | chr8:5064400-5064600 | Flanking Active TSS | Ganglion Eminence derived primary cultured neurospheres | brain |